Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 8-K Event Results of operations
  2. 8-K Event Results of operations
  3. 8-K Event Regulation FD disclosure · Other events
  4. 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
  5. 8-K Event Results of operations
  6. 8-K Event Regulation FD disclosure · Other events
  7. 8-K Event Shareholder vote results
  8. 8-K Event Results of operations
  9. 8-K Event Material agreement · Results of operations
  10. DEF 14A Proxy Proxy Statement
  11. 8-K Event Regulation FD disclosure · Other events
  12. 8-K Event Bylaws or fiscal year change
  13. 8-K Event Material agreement · Regulation FD disclosure · Other events
  14. 10-K Report Annual Report
  15. 8-K Event Results of operations
  16. 8-K Event Regulation FD disclosure · Other events
  17. 8-K Event Regulation FD disclosure · Other events
  18. 8-K Event Regulation FD disclosure · Other events
  19. 8-K Event Results of operations
  20. 8-K Event Other events

Page 1 of 8 · 160 filings